BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 16712945)

  • 1. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
    Rihmer Z; Akiskal H
    J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
    Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
    J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacology. FDA weighs suicide risk in children on antidepressants.
    Holden C
    Science; 2004 Feb; 303(5659):745. PubMed ID: 14764841
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidepressants use in pediatric populations.
    Gören JL
    Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS; Benazzi F
    J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants and suicidality: the basis of controversies.
    Marcinko D
    Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall WD; Lucke J
    Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H; Audenaert K; van Heeringen C
    Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.
    Morrato EH; Libby AM; Orton HD; Degruy FV; Brent DA; Allen R; Valuck RJ
    Am J Psychiatry; 2008 Jan; 165(1):42-50. PubMed ID: 17986680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
    Valuck RJ; Libby AM; Orton HD; Morrato EH; Allen R; Baldessarini RJ
    Am J Psychiatry; 2007 Aug; 164(8):1198-205. PubMed ID: 17671282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicide behaviour of patients treated with antidepressants.
    Rihmer Z; Gonda X
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):13-6. PubMed ID: 16841560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
    Libby AM; Brent DA; Morrato EH; Orton HD; Allen R; Valuck RJ
    Am J Psychiatry; 2007 Jun; 164(6):884-91. PubMed ID: 17541047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):476-96. PubMed ID: 17143567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the efficacy and safety of antidepressants in youth depression.
    Cheung AH; Emslie GJ; Mayes TL
    J Child Psychol Psychiatry; 2005 Jul; 46(7):735-54. PubMed ID: 15972068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.